Found: 58
Select item for more details and to access through your institution.
Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease.
- Published in:
- Annals of Neurology, 2024, v. 96, n. 3, p. 526, doi. 10.1002/ana.27003
- By:
- Publication type:
- Article
Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidance.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 7, p. 4625, doi. 10.1002/alz.13891
- By:
- Publication type:
- Article
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer's Disease: A Pragmatic Review for Clinicians.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 3, p. 885, doi. 10.1007/s40120-024-00620-x
- By:
- Publication type:
- Article
Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer's disease spectra.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 5, p. 1197, doi. 10.1002/acn3.52034
- By:
- Publication type:
- Article
Dementia with Lewy bodies Drug Therapies in Clinical Trials: 2022.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.077429
- By:
- Publication type:
- Article
Cortical and substantia nigra <sup>18</sup>F‐PI‐2620 tau PET signal in Lewy body disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079047
- By:
- Publication type:
- Article
Using plasma ptau181 in Lewy Body Disease spectrum for the identification of Alzheimer's disease co‐pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080197
- By:
- Publication type:
- Article
Cortical and substantia nigra 18F‐PI‐2620 tau PET signal in Lewy body disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081868
- By:
- Publication type:
- Article
Correction: Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.
- Published in:
- PLoS ONE, 2023, v. 18, n. 7, p. 1, doi. 10.1371/journal.pone.0285807
- By:
- Publication type:
- Article
Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 3, p. 727, doi. 10.1007/s40120-023-00467-8
- By:
- Publication type:
- Article
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-32515-6
- By:
- Publication type:
- Article
Introducing CARESSER: A framework for in situ learning robot social assistance from expert knowledge and demonstrations.
- Published in:
- User Modeling & User-Adapted Interaction, 2023, v. 33, n. 2, p. 441, doi. 10.1007/s11257-021-09316-5
- By:
- Publication type:
- Article
Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 1, p. 318, doi. 10.1002/alz.12814
- By:
- Publication type:
- Article
Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations.
- Published in:
- Translational Neurodegeneration, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40035-022-00299-w
- By:
- Publication type:
- Article
Perspectives and challenges in patient stratification in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01055-y
- By:
- Publication type:
- Article
Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations.
- Published in:
- Translational Neurodegeneration, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40035-022-00299-w
- By:
- Publication type:
- Article
Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations.
- Published in:
- Translational Neurodegeneration, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40035-022-00299-w
- By:
- Publication type:
- Article
Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-021-00946-w
- By:
- Publication type:
- Article
Alzheimer's disease diagnosis and management: Perspectives from around the world.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12334
- By:
- Publication type:
- Article
Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 1, p. 32, doi. 10.1001/jamaneurol.2021.4222
- By:
- Publication type:
- Article
Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment.
- Published in:
- Frontiers in Aging Neuroscience, 2021, p. 1, doi. 10.3389/fnagi.2021.718949
- By:
- Publication type:
- Article
Metabolic syndrome impact on cognitive composites domain scores and on white matter hyperintensities in subjective cognitive decline: The FACEHBI Cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051324
- By:
- Publication type:
- Article
Comparison of automated CLEIA and manual ELISA immunoassays for CSF AD biomarkers: The Fundació ACE Biomarker Research Program (FACEBREP).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051615
- By:
- Publication type:
- Article
The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00833-4
- By:
- Publication type:
- Article
Demencia con cuerpos de Lewy Dementia with Lewy bodies.
- Published in:
- Kranion, 2021, v. 16, n. 2, p. 72, doi. 10.24875/KRANION.M21000004
- By:
- Publication type:
- Article
Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83126-y
- By:
- Publication type:
- Article
Author Correction: Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Interaction of neuropsychiatric symptoms with APOE e4 and conversion to dementia in MCI patients in a memory clinic: Neuropsychiatry and behavioral neurology/Mild cognitive impairment/Early symptomatic disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.039739
- By:
- Publication type:
- Article
Gender and sex bias in clinical trial recruitment in Alzheimer's disease: Findings from Fundació ACE: Intersections of sex/gender and race/ethnicity in cognitive aging and Alzheimer's disease trajectories.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041234
- By:
- Publication type:
- Article
How gender and sex influence clinical trial recruitment in Alzheimer's disease: Findings from Fundació ACE Barcelona Alzheimer Treatment and Research Center: Health services research / Policy and plans.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041772
- By:
- Publication type:
- Article
Interaction of neuropsychiatric symptoms with APOE e4 and conversion to dementia in MCI patients in a memory clinic: Neuropsychiatry and behavioral neurology/Mild cognitive impairment/Early symptomatic disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039739
- By:
- Publication type:
- Article
Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77023-z
- By:
- Publication type:
- Article
Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-74704-7
- By:
- Publication type:
- Article
Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00602-9
- By:
- Publication type:
- Article
A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00594-6
- By:
- Publication type:
- Article
Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer's disease in a memory clinic.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-58399-4
- By:
- Publication type:
- Article
Author Correction: Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer's disease.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 10, p. 1333, doi. 10.1016/j.jalz.2019.06.4950
- By:
- Publication type:
- Article
Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-34577-3
- By:
- Publication type:
- Article
Exploring Genetic Associations of Alzheimer's Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes.
- Published in:
- Frontiers in Aging Neuroscience, 2018, p. 1, doi. 10.3389/fnagi.2018.00340
- By:
- Publication type:
- Article
P1‐540: NON‐SCHEDULED CONSULTATIONS CAN HELP TO IDENTIFY HIGHLY DEMANDING DEMENTIA PATIENTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P541, doi. 10.1016/j.jalz.2018.06.551
- By:
- Publication type:
- Article
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 5, p. 634, doi. 10.1016/j.jalz.2017.10.005
- By:
- Publication type:
- Article
Safety, tolerability and immunogenicity of an active anti-Aβ<sub>40</sub> vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, p. 1, doi. 10.1186/s13195-018-0340-8
- By:
- Publication type:
- Article
THE SPANISH VERSION OF FACE-NAME ASSOCIATIVE MEMORY EXAM (S-FNAME) PERFORMANCE IS RELATED TO AMYLOID BURDEN IN SUBJECTIVE COGNITIVE DECLINE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P228, doi. 10.1016/j.jalz.2017.07.112
- By:
- Publication type:
- Article
EXPLORING APOE GENOTYPE EFFECTS ON AD RISK AND BETA-AMYLOID BURDEN IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: THE FACEHBI STUDY RESULTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P296, doi. 10.1016/j.jalz.2017.06.208
- By:
- Publication type:
- Article
CORRELATIONS BETWEEN PLASMA AND BRAIN BETA-AMYLOID LEVELS IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: THE FUNDACIÓ ACE HEALTHY BRAIN INITIATIVE (FACEHBI).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1027, doi. 10.1016/j.jalz.2017.06.1446
- By:
- Publication type:
- Article
ARE THERE DIFFERENCES IN THE OPINION OF PATIENTS WITH ALZHEIMER DISEASE AND THEIR CAREGIVERS ABOUT HAVING SUPPORT FROM A SERVICE ROBOT AT HOME?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1412, doi. 10.1016/j.jalz.2017.06.2192
- By:
- Publication type:
- Article